Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
URGN
URGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
URGN News
UroGen Pharma Receives FDA Clearance for UGN-501 Clinical Study
6h ago
NASDAQ.COM
FDA Clearance for UGN-501 Initiates Phase 1 Clinical Study
7h ago
Newsfilter
Analysis of Biotech Companies' Stock Performance
2d ago
NASDAQ.COM
UroGen Pharma Shares Surpass Analyst Target Price
6d ago
NASDAQ.COM
UroGen CMO Sells Shares Amid Strategic Developments
Jul 01 2026
NASDAQ.COM
UroGen Pharma CMO Sells Shares in Open Market Transaction
Jul 01 2026
Fool
UroGen Pharma Executive Stock Transaction Overview
Jun 14 2026
Fool
UroGen Pharma Executive Reduces Shareholding
Jun 14 2026
NASDAQ.COM
UroGen Pharma Settles Patent Dispute with Teva Pharmaceuticals
Jun 02 2026
seekingalpha
Superstring Capital Reduces Stake in UroGen Pharma
May 23 2026
Fool
Superstring Capital Reduces Stake in UroGen Pharma
May 23 2026
NASDAQ.COM
Healthcare Stocks Rise 0.8% on NYSE Healthcare Index
May 13 2026
Yahoo Finance
Urogen Pharma CMO Mark Schoenberg Sells Shares
May 11 2026
Yahoo Finance
UroGen Pharma Reports Strong Q1 2026 Earnings with Significant ZUSDURI Growth
May 06 2026
seekingalpha
UroGen Pharma Q1 Earnings Beat Expectations
May 06 2026
seekingalpha
UroGen Pharma to Announce Q1 Earnings on May 6
May 05 2026
seekingalpha
Show More News
